Description
Release form
Tablets
Packing
30 pcs.
Pharmacological action
Betagistin acts mainly on the histamine H1 and H3 receptors of the inner ear and vestibular nuclei of the central nervous system. By direct agonistic action on the H] receptors of the vessels of the inner ear. and also indirectly through exposure to H3 receptors it improves microcirculation and capillary permeability, normalizes endolymph pressure in the labyrinth and cochlea. However, betahistine increases blood flow in the basilar artery.
It has a pronounced central effect, being an inhibitor of the Н3 receptors of the vestibular nerve nuclei. It improves the conductivity in the neurons of the vestibular nuclei at the level of the brain stem.
The clinical manifestation of these properties is a decrease in the frequency and intensity of dizziness, a decrease in tinnitus, and an improvement in hearing if it is reduced.
Indications
treatment and prevention of vestibular dizziness of various origins
syndromes, including dizziness and headache, tinnitus, progressive hearing loss, nausea and vomiting
disease or Meniere’s syndrome.
Contraindications
Hypersensitivity to any of the components of the drug in children under 18 years of age (due to lack of data).
With caution
Peptic ulcer of the gastrointestinal tract (including a history), pheochromocytoma. bronchial asthma. These patients should be regularly observed during treatment.
Use during pregnancy and lactation
Insufficient data to evaluate the effects of the drug during pregnancy and lactation.
In this regard, it is not recommended to take during pregnancy. At the time of treatment, it is necessary to stop breastfeeding.
Special instructions
>
is applied at each diaper (diaper) change. Dosage and administration
Betagistin is prescribed orally during meals.
Side effects
> 8 mg tablets:
Overdose of
2 tablets 3 times a day.
Improvement is usually noted already at the beginning of therapy, a stable therapeutic effect occurs after two weeks of treatment and may increase within a few months of treatment. The treatment is long. The duration of the drug is selected individually.
Storage conditions
Gastrointestinal disorders, hypersensitivity reactions from the skin (rash. itchy hives), quince edema.
Dosage
tablet form
Appointment
for Adults on purpose doctor
Indications
cerebrovascular accident, Meniere’s disease
Possible product names
BETAGISTIN 0.008 N30 TABLET / VERTEX
BETAGISTIN 0.008 N30 TABLET / OBOLENSLOZERL8 S30LBlONSPr8 Betagistin 8mg Tab. X30 (R)
Betahistinum tab 8mg N30 (pack control N10x3)
Vertex, Russia
